In a blockbuster deal between two of biopharma’s largest players, Bristol-Myers Squibb said Thursday it plans to buy Celgene (CELG) for $74 billion.

The transaction — the fourth-largest ever in pharma — joins two of the largest companies in oncology, both of which have been facing setbacks. Bristol-Myers pioneered the use of cancer medicines that work by priming the immune system, but its flagship blockbuster drug, Opdivo, has been surpassed by a rival medicine from Merck, especially in the market for lung cancer.

Unlock this article by subscribing to STAT Plus. To get you started, enjoy 50% off your first 3 months!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • THIS IS NOT AT ALL SURPRISING AND NEW TO I TREVOR MERCHANT , THE HEALTH CARE INDUSTRY OR SYSTEM IN THE UNITED STATES OF AMERICA .FIRSTLY DUE TO THE FACT THAT WE ARE SPENDING SO MUCH FUNDS EACH YEAR TET STILL THE RESULTS FROM ALL OF THIS IMMENSE FUNDS HAVE CONTINUED TO BE AND MORE WORSE EACH YEAR AS WE CONTINUE TO POUR MORE FUNDS DUE TO THE POWER ,INFLUENCE AND MISINFORMATION TO THE PUBLIC A SIGNIFICANT PERCENTAGE .FOR INSTANCE THE YEAR OF 2017 WE SPENT THREE POINT FIVE TRILLION DOLLARS YET STILL WE HAD EIGHTY THOUSANDS DEATHS FROM THE FLU ,THE VACCINE DID NOT WORK , HOSPITALS EMERGENCY ROOMS NATIONALLY ARE DEATH CHAMBERS WITH MERS AND SUPER BUGS , THEY BECOME MORE DEADLY AS THE DAYS GO BY. ONE REPORT STATES THAT YOU BECOME INFECTED WITH DEMENTIA GOING TO A EMERGENCY ROOM. THE ENTIRE HEALTH CARE SYSTEM IS OPERATED BY THE PHARMACEUTICAL EMPIRES .THE CHAIN HOSPITALS AND THE BRIBED DRUG DEALERS DOCTORS IN WHITE COATS . ALSO DO NOT FORGET THE CORRUPT AND DISGRACEFUL ,LIBERAL .RADICALS .ELITES POLITICIANS WHO MISLEAD AND INDOCTRINATE THE UNREAD .UNFORMED AND UNEDUCATED THAT THEY MUST GO TO HOSPITALS AND TAKE DRUGS FOR ANY SIMPLE AILMENTS THEY MAY ENCOUNTER , AS THESE CORRUPT POLITICIANS TEL L THEM THAT THEY WILL PUT ANY AMOUNT OF FUNDS IN THE HEALTH CARE SYSTEM AND THAT WITH THE LARGE AMOUNT OF FUNDS THAT ONLY BY ITSELF WILL MAKE YOU HEALTH AND LIVE LONGER . TOTALLY AND FALSELY A LIE . MORE TO COME .TREVOR MERCHANT .BRONX ,NEW YORK CITY .THURSDAY .JAN . 03. 2019

Your daily dose of news in health and medicine

Privacy Policy